Christina Ha, MD

Mayo Clinic Arizona

Poster(s):

• P3637 - Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3638 - Characterization of Hospitalized Patients With Ulcerative Colitis Treated With Tofacitinib in the OCTAVE Clinical Program for up to 7.8 Years
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT